BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

U.S. Navy 



     
Phone: Fax:


SEARCH JOBS




Collaborations

Antex Biologics, Inc. 





 Company News
U.S. Navy Approves Start Of CEL-SCI (CVM)’s Phase I Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients 2/3/2014 9:09:14 AM    More...
CEL-SCI (CVM) Announces Cooperative Research and Development Agreement (CRADA) for Multikine With U.S. Navy 10/7/2013 9:54:35 AM    More...
Sparton Corporation (SPA) Venture Awarded $17.9 Million U.S. Navy Contract 2/8/2013 9:23:29 AM    More...
Oxygen Biotherapeutics, Inc. (OXBO) Signs Cooperative Research and Development Agreement With U.S. Navy to Investigate the Use of Oxycyte PFC Emulsion as an Adjunctive Treatment of Complex Infected Wounds and Related Injuries 10/3/2012 10:07:03 AM    More...
Dental Equipment-Maker A-dec Lands $39.5 Million U.S. Navy Contract 8/17/2012 8:08:02 AM    More...
Oxygen Biotherapeutics, Inc. (OXBO) and U.S. Navy Expand Collaboration With a Cooperative Research & Development Agreement to Study Oxycyte® for Treatment of Hemorrhagic Shock 8/2/2012 10:39:27 AM    More...
U.S. Navy Advances Dengue DNA Vaccine Using Vical Incorporated (VICL)'s Vaxfectin(R) Adjuvant 3/5/2012 10:05:17 AM    More...
U.S. Navy Doctor's Drug Study Under Scrutiny 5/20/2011 10:56:01 AM    More...
Sangart, Inc. Announces Cooperative Research and Development Agreement With the U.S. Navy to Evaluate MP4 Molecule in Traumatic Brain Injury 12/6/2010 8:58:17 AM    More...
ADA Technologies Awarded $80K Contract from U.S. Navy 9/29/2010 11:11:11 AM    More...
12

//-->